FEBS Letters
Volume 583, Issue 12 , Pages 1916-1922, 18 June 2009

Activation of NFAT signal by p53-K120R mutant

Edited by Varda Rotter

  • Natsuko Shinmen

      Affiliations

    • Department of Biochemistry and Genetics, Chiba University, Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba 260-8670, Japan
    • Department of Legal Medicine, Showa University School of Medicine, Hatanodai 1-5-8, Shinagawa-ku, Tokyo 142-8555, Japan
  • ,
  • Toshifumi Koshida

      Affiliations

    • Department of Biochemistry and Genetics, Chiba University, Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba 260-8670, Japan
  • ,
  • Takeshi Kumazawa

      Affiliations

    • Department of Legal Medicine, Showa University School of Medicine, Hatanodai 1-5-8, Shinagawa-ku, Tokyo 142-8555, Japan
  • ,
  • Keizo Sato

      Affiliations

    • Department of Legal Medicine, Showa University School of Medicine, Hatanodai 1-5-8, Shinagawa-ku, Tokyo 142-8555, Japan
  • ,
  • Hideaki Shimada

      Affiliations

    • Department of Gastroenterological Surgery, Chiba Cancer Center, Nitona-cho 666-2, Chuo-ku, Chiba 260-8717, Japan
  • ,
  • Tomoo Matsutani

      Affiliations

    • Department of Neurological Surgery, Chiba University, Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba 260-8670, Japan
  • ,
  • Yasuo Iwadate

      Affiliations

    • Department of Neurological Surgery, Chiba University, Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba 260-8670, Japan
  • ,
  • Masaki Takiguchi

      Affiliations

    • Department of Biochemistry and Genetics, Chiba University, Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba 260-8670, Japan
  • ,
  • Takaki Hiwasa

      Affiliations

    • Department of Biochemistry and Genetics, Chiba University, Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba 260-8670, Japan
    • Corresponding Author InformationCorresponding author. Fax: +81 43 226 2037.

Received 3 April 2009; accepted 27 April 2009. published online 04 May 2009.

Abstract 

The tumor suppressor p53 is activated by phosphorylation and/or acetylation. We constructed 14 non-phosphorylated, 11 phospho-mimetic, and 1 non-acetylated point p53 mutations and compared their transactivation ability in U-87 human glioblastoma cells by the luciferase reporter assay. Despite mutations at the phosphorylation sites, only the p53-K120R and p53-S9E mutants had marginally reduced activities. On the other hand, the Nuclear factor of activated T-cells (NFAT)-luciferase reporter was more potently activated by p53-K120R than by wild-type p53 and other mutants in glioblastoma, hepatoma and esophageal carcinoma cells. This suggests that acetylation at Lys-120 of p53 negatively regulates a signaling pathway leading to NFAT activation.

Keywords: Nuclear factor of activated T-cell, p53, Luciferase reporter assay, Calcium signal

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0014-5793(09)00334-2

doi:10.1016/j.febslet.2009.04.041

FEBS Letters
Volume 583, Issue 12 , Pages 1916-1922, 18 June 2009